Cytokinetics | CYTK - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Acadia Pharmaceuticals USD 270.12M 2.55M 2026-06
Amgen USD 11.69B 6.9B 2026-06
Arca Biopharma USD 36.43M 2M 2026-03
Bayer EUR 10.04B 168M 2026-06
Biogen USD 2.98B 1.02B 2026-06
Brainstorm Cell Therapeutics USD 2.05M 198K 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cytokinetics USD 207.8M 7.22M 2026-06
Eisai JPY 209.6B 6.14B 2026-06
Eli Lilly USD 10.52B 496M 2026-06
Exelixis USD 380.28M 20.8M 2026-06
Geron USD 52.07M 6.73M 2026-03
Halozyme Therapeutics USD 193.34M 1.15M 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Ligand Pharmaceuticals USD 55.1M 20.75M 2026-06
Merck USD 15.77B 2.4B 2026-06
Novartis USD 10.2B 912M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06